Suchergebnisse - "Chamorey, Emmanuel"

PubPharm (33)

1

Validation of RUBY for Breast Cancer Knowledge Extraction From a Large French Electronic Medical Record System

enthalten in: JCO clinical cancer informatics | 2023

von Schiappa, R. | Contu, S. | Culie, D. | +8

2

Breakthrough infections due to SARS-CoV-2 Delta variant : relation to humoral and cellular vaccine responses

enthalten in: Frontiers in immunology | 2023

von Buscot, M. | Cremoni, M. | Graça, D. | +9

3

RUBY : Natural Language Processing of French Electronic Medical Records for Breast Cancer Research

enthalten in: JCO clinical cancer informatics | 2022

von Schiappa, R. | Contu, S. | Culie, D. | +8

4

Observational, prospective, phase 4 study in patients with first-line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum-based therapy : DIRECT

enthalten in: Cancer reports (Hoboken, N.J.) | 2022

von Guigay, J. | Chamorey, E. | Lefebvre, G. | +8

5

Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies

enthalten in: Nature communications | 2022

von Re, D. | Seitz-Polski, B. | Brglez, V. | +10

6

Prospective Multicenter Validation of the Detection of ALK Rearrangements of Circulating Tumor Cells for Noninvasive Longitudinal Management of Patients With Advanced NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2021

von Ilié, M. | Mazières, J. | Chamorey, E. | +117

7

Association of TRF2 expression and myeloid-derived suppressor cells infiltration with clinical outcome of patients with cutaneous melanoma

enthalten in: Oncoimmunology | 2021

von Ilié, M. | Lantéri, E. | Chamorey, E. | +12

8

Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma

enthalten in: Communications biology | 2021

von Dufies, M. | Verbiest, A. | Cooley, L. | +24

9

The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy

enthalten in: Theranostics | 2021

von Hagege, A. | Ambrosetti, D. | Boyer, J. | +13

10

Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma

enthalten in: Oncoimmunology | 2020

von Montemagno, C. | Hagege, A. | Borchiellini, D. | +11